top of page

Catching up with Roberto Bellini one year after he sold BELLUS Health to GSK for $2 billion

Roberto Bellini introduces us to his new investment firm and looks back on lessons learned from selling BELLUS to GSK.


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page